UPDATED: FDA is considering FOURTH dose of COVID-19 vaccine and making it an annual shot as cases across the US drop 43% over the past week and 87% since the peak of the Omicron variant

February 25, 2022February 25, 2022 Tina Marie (Ms. Cat)

FDA is considering FOURTH dose of COVID-19 vaccine and making it an annual shot as cases across the US drop 43% over the past week and 87% since the peak of the Omicron variant

A fourth booster shot of either the Pfizer or Moderna vaccine could start an annual booster shot campaign, one of the people familiar with the FDA’s planning said.

I’m not buying the media’s scaremongering about the second omicron variant!

Omicron-targeted vaccines do no better than original jabs in early tests

February 17, 2022February 17, 2022 Tina Marie (Ms. Cat)

Omicron-targeted vaccines do no better than original jabs in early tests

FDA executive officer is caught on hidden camera admitting Biden will force an ANNUAL Covid shot that would be a ‘recurring fountain of revenue’ for drug firms

February 17, 2022February 17, 2022 Tina Marie (Ms. Cat)

FDA executive officer is caught on hidden camera admitting Biden will force an ANNUAL Covid shot that would be a ‘recurring fountain of revenue’ for drug firms

J&J pauses production of its Covid-19 vaccine despite persistent need 💰

February 15, 2022February 15, 2022 Tina Marie (Ms. Cat)

J&J pauses production of its Covid-19 vaccine despite persistent need

The facility, in the Dutch city of Leiden, has instead been making an experimental but potentially more profitable vaccine to protect against an unrelated virus.
…
But poorer countries remain reliant on Johnson & Johnson’s vaccine, which does not require ultracold refrigeration. It has been shown to provide strong and long-lasting protection against severe disease across variants, including omicron, when given as a two-shot regimen. As a single shot, the vaccine is less expensive and relatively easy to give to hard-to-reach populations.
…
Unlike companies such as Pfizer and Moderna, which have reaped billions of dollars in profits, Johnson & Johnson did not find the COVID vaccine to be a big moneymaker.
….
Since production of the COVID vaccine was halted late last year, the Netherlands plant has been manufacturing an experimental vaccine against respiratory syncytial virus, or RSV, that will be used for a clinical trial in older adults in wealthy countries, a person familiar with the matter said. Even if it proves effective, the vaccine is not expected to become available for several years.